Public Opinion Is Unified on Lowering Drug Prices. Why Are Leaders Settling for Less?

Democrats and Republicans are crystal clear in polls that they want government to be allowed to negotiate down high drug prices. Americans pay nearly three times as much for drugs as patients in dozens of other countries.

Read More

With Fed Vaccine Mandate On Hold, What Now?

On Nov. 5, the U.S. Occupational Safety and Health Administration (OSHA) published nearly 500 pages of emergency temporary standards (ETS) that, among other things, would have required employers with 100 or more employees to require their employees to be fully vaccinated days into the new year.

Read More

California COVID: Good Case Numbers but Surge Threat Remains

California now has one of the lowest coronavirus infection rates in the country, with 1.9% of people testing positive for the disease in the last week as the nation’s most populous state has so far avoided the uptick feared heading into the end-of-year holidays.

Read More

Demand For Non-Medical Benefits Expected To Grow 20% In The Next Five Years

In the post-pandemic world, the demand for expanded benefits will not be a short-lived trend, a new report suggests. The new study by LIMRA and EY finds that non-medical workplace benefits will grow by 20% over the next five years, and said that hybrid work arrangements, growing diversity, and innovations in technology will all contribute to an ...

Read More

CVS To Close Around 900 Stores, Nearly 10% Of Its Locations

CVS Health is closing 900 stores over the next three years, amounting to nearly 10% of its footprint, in response to the changing of “consumer buying patterns.” The drug store chain said Thursday that the closures will result in a retail presence that ensures it has the “right kinds of stores in the right locations ...

Read More

Here Are The Policies And Reforms That Could Reshape Healthcare In The $2T Bill Just Passed By The House

The House passed a massive, roughly $2 trillion infrastructure package that will give Medicare the power to narrowly negotiate prices on certain prescription drugs and close the Medicaid coverage gap. The package, called the Build Back Better Act, advanced out of the House late Thursday by a vote of 220 to 213. It now heads to ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square